- Home
- MREO
MREO
Mereo BioPharma Group plc
as 01-22-2025 4:00pm EST
| Founded: | 2015 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $7.83 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.52 - $5.02 | Next Earning Date: | 02-13-2025 |
| Revenue: | $1,000,000 | Revenue Growth: | -88.89% |
| Revenue Growth (this year): | -16.86% | Revenue Growth (next year): | 54.47% |
Latest Mereo BioPharma Group plc News
MREO Breaking Stock News: Dive into MREO Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
Mereo BioPharma Provides Update on Lead Clinical Programs
GlobeNewswire
16 days ago
Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Insider Monkey
23 days ago
Why Mereo BioPharma (MREO) Is One of the Best Biotech Penny Stocks to Invest in Now?
TipRanks
2 months ago
Mereo BioPharma initiated with a Buy at Jefferies
GuruFocus.com
2 months ago
Mereo BioPharma Stock Climbs Following Jefferies' Buy Rating, Upside Potential of 89%
MT Newswires
2 months ago
Mereo BioPharma Shares Rise After Jefferies Begins Coverage at Buy
MT Newswires
2 months ago
Jefferies Initiates Mereo BioPharma at Buy With $7 Price Target
GlobeNewswire
2 months ago
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference
Compare MREO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MREO Mereo BioPharma Group plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.